FDA Approves Cabozantinib for Differentiated Thyroid Cancer
The US Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx) for the treatment of...
Increase in Thyroid Cancer Rates Points to Overscreening
The incidence of thyroid cancer cases has increase...